BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 3, 2007
View Archived Issues
Biogen Pays Cardiokine $50M In Deal On Hyponatremia Drug
Cardiokine Inc. is getting $50 million up front in a potential $220 million deal with Biogen Idec Inc. covering the vasopressin receptor antagonist lixivaptan. (BioWorld Today)
Read More
PIPE To Give VIA $25 Million To Push Forward CV Trials
Read More
GSK Passes Up Theravance Stock Buy; Alliance Still Intact
Read More
PSivida Adds $18M In ADS Offering For Ongoing R&D
Read More
Holiday Notice
Read More
Other News To Note
Read More
Clinic Roundup
Read More